These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27289271

  • 1. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    Drug Alcohol Depend; 2016 Aug 01; 165():143-50. PubMed ID: 27289271
    [Abstract] [Full Text] [Related]

  • 2. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    Nurs Res; 2017 Aug 01; 66(2):134-144. PubMed ID: 28252574
    [Abstract] [Full Text] [Related]

  • 3. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
    Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G.
    Ther Drug Monit; 2017 Oct 01; 39(5):550-555. PubMed ID: 28723731
    [Abstract] [Full Text] [Related]

  • 4. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ.
    Addict Biol; 2013 Jul 01; 18(4):709-16. PubMed ID: 21790905
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Pain Tolerance between Opioid Dependent Patients on Methadone Maintenance Therapy (MMT) and Opioid Naive Individuals.
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    J Pharm Pharm Sci; 2016 Jul 01; 19(1):127-36. PubMed ID: 27096697
    [Abstract] [Full Text] [Related]

  • 6. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB.
    Clin Pharmacol Ther; 2005 Dec 01; 78(6):593-604. PubMed ID: 16338275
    [Abstract] [Full Text] [Related]

  • 7. Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    Am J Drug Alcohol Abuse; 2016 Sep 01; 42(5):587-596. PubMed ID: 27284701
    [Abstract] [Full Text] [Related]

  • 8. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H, McLaughlin P, Gillis C, Osselton MD.
    Am J Perinatol; 2017 Jul 01; 34(9):918-921. PubMed ID: 28320034
    [Abstract] [Full Text] [Related]

  • 9. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M.
    Mol Diagn Ther; 2010 Jun 01; 14(3):171-8. PubMed ID: 20560679
    [Abstract] [Full Text] [Related]

  • 10. Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
    Victorri-Vigneau C, Verstuyft C, Bouquié R, Laforgue EJ, Hardouin JB, Leboucher J, Le Geay B, Dano C, Challet-Bouju G, Grall-Bronnec M.
    Br J Clin Pharmacol; 2019 Jul 01; 85(7):1538-1543. PubMed ID: 30907440
    [Abstract] [Full Text] [Related]

  • 11. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
    Chawar C, Hillmer A, Lamri A, Kapczinski F, Thabane L, Pare G, Samaan Z.
    PLoS One; 2021 Jul 01; 16(12):e0261201. PubMed ID: 34910759
    [Abstract] [Full Text] [Related]

  • 12. Relationship between Serum Methadone Concentration and Cold Pressor Pain Sensitivity in Patients Undergoing Methadone Maintenance Therapy.
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    Iran J Pharm Res; 2018 Jul 01; 17(Suppl):8-16. PubMed ID: 29796025
    [Abstract] [Full Text] [Related]

  • 13. Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.
    Chiang YC, Wang RY, Huang CL, Chen SH, Ho WJ, Lane HY, Ho IK, Yang HT, Ma WL.
    J Cell Mol Med; 2017 Dec 01; 21(12):3552-3564. PubMed ID: 28699698
    [Abstract] [Full Text] [Related]

  • 14. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
    Dobrinas M, Crettol S, Oneda B, Lahyani R, Rotger M, Choong E, Lubomirov R, Csajka C, Eap CB.
    Pharmacogenet Genomics; 2013 Feb 01; 23(2):84-93. PubMed ID: 23249875
    [Abstract] [Full Text] [Related]

  • 15. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.
    Robinson KM, Eum S, Desta Z, Tyndale RF, Gaedigk A, Crist RC, Haidar CE, Myers AL, Samer CF, Somogyi AA, Zubiaur P, Iwuchukwu OF, Whirl-Carrillo M, Klein TE, Caudle KE, Donnelly RS, Kharasch ED.
    Clin Pharmacol Ther; 2024 Oct 01; 116(4):932-938. PubMed ID: 38863207
    [Abstract] [Full Text] [Related]

  • 16. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
    Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B.
    J Pain; 2009 Mar 01; 10(3):316-22. PubMed ID: 19101210
    [Abstract] [Full Text] [Related]

  • 17. Chronic and acute pain and pain management for patients in methadone maintenance treatment.
    Eyler EC.
    Am J Addict; 2013 Jan 01; 22(1):75-83. PubMed ID: 23398230
    [Abstract] [Full Text] [Related]

  • 18. Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.
    Dennis BB, Bawor M, Thabane L, Sohani Z, Samaan Z.
    PLoS One; 2014 Jan 01; 9(1):e86114. PubMed ID: 24489693
    [Abstract] [Full Text] [Related]

  • 19. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
    AlMeman AA, Ismail R, Perola M.
    Drug Metab Lett; 2016 Jan 01; 10(3):213-218. PubMed ID: 27515451
    [Abstract] [Full Text] [Related]

  • 20. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
    Liu CC, Fang CP, Liu TH, Kuo HW, Liu SC, Wang SC, Chen ACH, Liu YL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr 20; 83():92-98. PubMed ID: 29330135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.